申请人:THE UNITED STATES OF AMERICA,
as represented by THE SECRETARY,
U.S. DEPARTMENT OF COMMERCE
公开号:EP0531419B1
公开(公告)日:1999-07-28
US5672593A
申请人:——
公开号:US5672593A
公开(公告)日:1997-09-30
US5731301A
申请人:——
公开号:US5731301A
公开(公告)日:1998-03-24
US5808038A
申请人:——
公开号:US5808038A
公开(公告)日:1998-09-15
[EN] BISTRIAZENES AS CHEMOTHERAPEUTIC AGENTS
申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
公开号:WO1993009089A1
公开(公告)日:1993-05-13
(EN) The present invention is directed to bistriazene compounds, pharmaceutical compositions containing effective anti-cancer amounts of these compounds, a method for treating cancer comprising administering to affected subjects an anti-cancer effective amount of a bistriazene compound, and the use of bistriazene compounds as cross-linking reagents applicable to the synthesis and manipulation of polymeric macromolecules.(FR) Composés de bistriazènes, compositions pharmaceutiques contenant des doses anticancéreuses efficaces de ces composés, procédé de traitement du cancer consistant à administrer aux sujets touchés une dose anticancéreuse efficace d'un composé de bistriazène, et utilisation de composés de bistriazènes comme réactifs de réticulation applicables à la synthèse et à la manipulation de macromolécules polymères.